Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov 15:10:1410.
doi: 10.3389/fphys.2019.01410. eCollection 2019.

Proteomic Markers of Non-functional Overreaching During the Race Across America (RAAM): A Case Study

Edward K Merritt  1 , David C Nieman  2 , Brian R Toone  3 , Arnoud Groen  4 , Artyom Pugachev  4
Affiliations

Proteomic Markers of Non-functional Overreaching During the Race Across America (RAAM): A Case Study

Edward K Merritt et al. Front Physiol. .

Abstract

In a previous study, proteomics procedures identified blood proteins as potential overreaching and overtraining biomarkers, and a targeted proteomics panel of 21 proteins was developed.

Purpose: To measure targeted blood protein changes in an ultraendurance cyclist competing in RAAM.

Methods: The athlete underwent testing 4-week pre-RAAM and 4-day post-RAAM to determine body composition and aerobic capacity. During RAAM training distress score (TDS) and body mass were measured daily. Power output and heart rate (HR) were measured during cycling. Blood sampling for proteomic analysis occurred 4 weeks, 24, and 2 h before the start, twice per day of the race, and after 1 and 4 days recovery.

Results: The athlete completed the 4941 km race in 10.1 days at a speed of 24.5 km/h with 20 total hours of sleep. TDS was very low, 1, pre-RAAM and increased to very high, 47, at the finish. Post-RAAM maximal aerobic capacity and HR were 6.3 and 5.7% lower (61.6 vs. 57.5 mL.kg-1.min-1 and 192 bpm vs. 181 bpm). Body composition did not change. The change in blood proteins was calculated using pre-race samples and samples collected on days 8, 9, and recovery day 1. The blood proteins with the largest increase were complement component C7 (359%), complement C4-B (231%), serum amyloid A-4 protein (210%), inter-alpha-trypsin inhibitor heavy chain H4 (191%), and alpha-1-antitrypsin (188%).

Conclusion: The RAAM athlete exhibited non-functional overreaching symptoms including increased training distress and decreased work capacity. Proteomic analysis indicated large increases for immune-related proteins involved with complement activation and the acute phase response, which could be useful biomarkers for non-functional overreaching.

Keywords: RAAM; cycling; overreach; overtraining syndrome; proteomics; ultraendurance.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Percent change in targeted blood proteins during RAAM. A previous study (Nieman et al., 2018) determined that these proteins are not acutely upregulated following an exercise bout, potentially implicating them as strong candidates for NFOR monitoring in individuals.
FIGURE 2
FIGURE 2
Intensity values for serum amyloid A4 (SAA4) before, during (morning and evening), and after RAAM competition.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Aubry A., Hausswirth C., Louis J., Coutts A. J., Le Meur Y. (2014). Functional overreaching: the key to peak performance during the taper? Med. Sci. Sports Exerc. 46 1769–1777. 10.1249/MSS.0000000000000301 - DOI - PubMed
    1. Balfoussia E., Skenderi K., Tsironi M., Anagnostopoulos A. K., Parthimos N., Vougas K., et al. (2014). A proteomic study of plasma protein changes under extreme physical stress. J. Proteomics 98 1–14. 10.1016/j.jprot.2013.12.004 - DOI - PubMed
    1. Bouwman F. G., van Ginneken M. M. E., Noben J.-P., Royackers E., de Graaf-Roelfsema E., Wijnberg I. D., et al. (2010). Differential expression of equine muscle biopsy proteins during normal training and intensified training in young standardbred horses using proteomics technology. Comp. Biochem. Physiol. Part D Genomics Proteomics 5 55–64. 10.1016/j.cbd.2009.11.001 - DOI - PubMed
    1. Cywinska A., Gorecka R., Szarska E., Witkowski L., Dziekan P., Schollenberger A. (2010). Serum amyloid a level as a potential indicator of the status of endurance horses. Equine Vet. J. 42(Suppl. 38), 23–27. 10.1111/j.2042-3306.2010.00280.x - DOI - PubMed
    1. Grove J. R., Main L. C., Partridge K., Bishop D. J., Russell S., Shepherdson A., et al. (2014). Training distress and performance readiness: laboratory and field validation of a brief self-report measure. Scand. J. Med. Sci. Sports 24 e483–e490. 10.1111/sms.12214 - DOI - PubMed